Medical Information Only. Consult your healthcare provider before considering clinical trial enrollment.
Dentin Hypersensitivity: later-stage trial registry
3 of 5 indexed Dentin Hypersensitivity trials are currently recruiting, with more weight in Phase 3-4.
Corpus placement: #3,391 of 28,707 conditions by registered trial count.
5 US clinical trials · 3 currently recruiting · #3,391 of 28,707 conditions by registered trial count
Dentin Hypersensitivity: 5 US clinical trials tracked, 3 recruiting.
Dentin Hypersensitivity is the subject of 5 registered US clinical trials on ClinicalTrials.gov, 3 of them currently open to new participants. 1 are in Phase 3-4 (later-stage) and 0 in Phase 1-2 (earlier-stage). The most active sponsor is HALEON, running 3 of these trials.
Enrollment posture brief
Registry condition dentin-hypersensitivity
OPEN 3 | RECR 60% | LATE 1 | EARLY 0 | RANK #3391 | SPON 3
Volume-matched condition peers
Nearest open-share peer: Acute Kidney Injury (AKI) (60% recruiting · 5 trials)
Dentin Hypersensitivity lists 3 open slots (60% of 5 indexed trials). Peers are matched on registered volume, not therapeutic-area browse lists. How peer matching works →
Key findings
What ClinicalTrials.gov does not surface for Dentin Hypersensitivity on its own pages , computed from the registry mirror as of 2026-08-08. Each line carries its own denominator so it can be quoted as it stands.
-
Dentin Hypersensitivity is recruiting above its size-band peers.
3 of 5 indexed trials (60%) are open to enrollment, against a 46.5% average across 27,806 conditions with fewer than 20 trials. The peer set uses the same ClinicalTrials.gov-derived counts as this page.
-
One sponsor concentrates Dentin Hypersensitivity research.
HALEON accounts for 3 of 5 trials (60%). 3 distinct sponsors appear on at least one study for this condition label.
-
Typical Dentin Hypersensitivity enrolment sits around 120 participants.
Median target enrolment is 120 among the 5 trials that report a genuine target (sentinel values excluded). 0 of those (0%) plan for fewer than 100 participants.
-
Dentin Hypersensitivity research is mostly interventional.
4 interventional and 1 observational studies make up this index (80% interventional). Study type is sponsor-reported on ClinicalTrials.gov.
Open and recent trials
5 total, page 1 of 1
Clinical Study to Investigate the Antihypersensitivity Efficacy of a Novel Dentifrice
HALEON
NCT07215767
A Study Evaluating Oral-Health-Related Quality of Life and Treatment Patterns Among Dentin Hypersensitivity Sufferers
HALEON
NCT07337109
A Study to Investigate the Tooth Whitening and Dentin Hypersensitivity Effectiveness of Two Experimental Toothpastes
HALEON
NCT07297732
A Clinical Study to Assess the Effects of Various Dentifrice Technologies on Dentinal Hypersensitivity
Procter and Gamble
NCT03965039
A Comparison Study of Hypersensitivity Treatment
Solventum US
NCT05768373
Phase Distribution
| Phase | Trial count |
|---|---|
| Phase 3 | 1 |
Top Sponsors
Named interventions
Most-linked intervention names on Dentin Hypersensitivity records (sponsor-reported on ClinicalTrials.gov). Counts are trial links, not unique products.
US sites by state
Facility locations filed on Dentin Hypersensitivity trials. A trial with sites in several states counts in each.
Source: ClinicalTrials.gov, National Library of Medicine. Data is informational only.
Related
What to do with this Dentin Hypersensitivity page
5 registered trials, 3 currently recruiting, is a starting point for a conversation, not a diagnosis or a recommendation.
- 3 Dentin Hypersensitivity trials are currently recruiting, check eligibility criteria before contacting a site. Browse recruiting trials
- HALEON sponsors the most Dentin Hypersensitivity trials on record, review their full trial history before evaluating a specific study. See HALEON's trials
- Bring the specific trial ID (NCT number) to your own doctor before enrolling, this page is a directory, not medical guidance. Read the trial-finding guide
Trial and recruiting counts reflect ClinicalTrials.gov registry status as of the data vintage above; individual trial eligibility and enrollment status can change.
Every figure on PlainTrial is rendered directly from the ClinicalTrials.gov registry, no number is typed in by an editor. This Dentin Hypersensitivity condition card totals 5 registered trials; most-linked intervention 3M™ Vanish™; top US site state Nevada. See our editorial standards & corrections policy, the methodology behind these numbers, the data changelog, or report a data error.